• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Agios and Alnylam sign agreement for siRNA candidate

cafead

Administrator
Staff member
  • cafead   Aug 04, 2023 at 12:22: PM
via Agios Pharmaceuticals has signed a license agreement with Alnylam Pharmaceuticals for preclinical Small interfering RNA (siRNA) development candidate to treat polycythemia vera (PV).

article source
 

<